'This is wrong on so many levels that it's hard to know where to begin.' 'If there is one thing that science-based medicine requires to function properly, it's good science and well-designed clinical trials subjected to rigorous peer review. Moreover, that review has to be unbiased, and the journals publishing them cannot be tainted with undue influence of big pharma.
'A while back, I wrote about JAMA editor Catherine DeAngelis, her crusade against undisclosed conflicts of interest by the authors of journal articles, and, most importantly, her hypocrisy and heavy-handed attempt to slap down a researcher and educator who pointed out the failure of a JAMA author to disclose that he had been on the speakers' bureau for a pharmaceutical company whose drug he had been studying.
'What made this offense particularly egregious was that the study in question had a rather glaring methodological flaw that, when corrected for, revealed that nonpharmacological therapy was equal to that of the drug company's medication, which the author admitted when it was pointed out to him.
What does one do when the whole journal--articles and all--is nothing more than a glossy advertisement for a pharmaceutical company's products?'
Read more...
